Showing results (1961-1970 of 2,072) with videos related to

Sort By:
Pageof 208
Nature Communications|February 5, 2025
Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.
Blood|June 20, 2024
Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic targetTyler W Benson, Mindy M Pike, Anthony Spuzzillo, et al.
Research Square|June 19, 2023
Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.
Frontiers in Genetics|June 29, 2019
A <i>Trans</i>-Ethnic Genome-Wide Association Study of Uterine FibroidsTodd L Edwards, Ayush Giri, Jacklyn N Hellwege, et al.
JAMA Network Open|October 5, 2023
Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical TrialsPaul A Harris, Sarah E Dunsmore, Jane C Atkinson, et al.
The British Journal of Ophthalmology|May 4, 2026
Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi studyRoshan Karri, David C Sousa, Xavier Hadoux, et al.
Nature Biomedical Engineering|June 11, 2026
Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophyYu Tian, Yutong Liu, Yuhao Tong, et al.
American Journal of Human Genetics|August 5, 2017
Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA DamageJoshua A Betts, Mahdi Moradi Marjaneh, Fares Al-Ejeh, et al.
Neurology|October 5, 2012
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathologyDebby Tsuang, James B Leverenz, Oscar L Lopez, et al.
Cell Reports|February 27, 2020
Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral LeishmaniasisRajiv Kumar, Patrick T Bunn, Siddharth Sankar Singh, et al.
Pageof 208